Medical Nitrile Gloves Market: Information by Type, by End User and Region —Forecast till 2027
出 版 商：Market Research Future
出版日期：2021/08/01
頁 數：125頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Multi-User License)
USD 6,250 (Multi-User License)
Medical Nitrile Gloves Market—Forecast till 2027
Market Analysis
The medical nitrile gloves market is anticipated to register a significant CAGR of 13.47% to surpass USD 5,897.81 million by the end of 2027. The worldwide clinical nitrile gloves market is developing at a consistent rate because of the increasing number of patient pools experiencing COVID-19 combined with the expanding request because of lack of nitrile gloves assist new contestants with getting to the market. The supply chain examination of the clinical nitrile gloves market involves significant parts beginning from the research and product development (R&D) trailed by the assembling of the items, appropriation, and deals, and finishes with post-deals checking.
The market is profoundly cutthroat, with players contending and teaming up to acquire a generous portion of the overall industry. Venture into fresher undiscovered business sectors, novel item dispatches, and choices attempted to accomplish functional proficiency are key factors that help market development. Our investigation uncovered that market players had taken on various systems and imaginative exploration and advancement methods to grow their business and secure their situation in the worldwide nitrile gloves market. As of late, joint efforts by key parts for item improvement and territorial venture into undiscovered business sectors have been utilized as a system to get functional productivity.
Segment Overview
Medical Nitrile Gloves Market has been classified into Type, usage, application, distribution channel, and end-user.
Based on type segment the global market is bifurcated into Non-Powdered and Powdered. Medical Nitrile Gloves Market, in terms of Usage, is divided into Disposable and Reusable. The application segment bifurcates the market into Examination and Surgical.
Medical Nitrile Gloves Market, by Distribution Channel, is bifurcated into Direct Selling and Medical Store. Based on End Users the global market is categorized into Hospitals & Clinics, Diagnostic Centers, ASCs, Rehabilitation Centers, and Others.
Regional Analysis
Geographically, the report on the global nitrile gloves market has been classified into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is likely to drive the global market owing to the dominating market in 2020 and is probably going to keep on directing during the evaluation time frame. This is credited to the huge number of patients experiencing COVID-19, the high pace of surgeries, and positive import arrangements in the area. The regional market growth is attributed to the prospering medical care industry, adopted technology innovations, and the presence of major market players in North America.
Europe is anticipated to register the second largest market for nitrile gloves followed by Asia-Pacific.
Key Players
The major players of the global Nitrile Gloves Market are Mercator Medical S.A, (Poland), Hartalega Holdings Berhad (Malaysia), Top Glove Corporation Bhd (Malaysia), Kossan Rubber Industries Bhd (KRI) (Malaysia), Ansell Healthcare (US), Medline Industries, In (US), 3M (US), Dynarex Corporation (US), Shield Scientific B.V. (Netherland), McKesson Corporation (US), Honeywell International Inc (US), Atrium Medical Care (US), Kimberly Clark (US), SHIELD Scientific (France), and Supermax Healthcare Limited (UK).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Market Analysis
The medical nitrile gloves market is anticipated to register a significant CAGR of 13.47% to surpass USD 5,897.81 million by the end of 2027. The worldwide clinical nitrile gloves market is developing at a consistent rate because of the increasing number of patient pools experiencing COVID-19 combined with the expanding request because of lack of nitrile gloves assist new contestants with getting to the market. The supply chain examination of the clinical nitrile gloves market involves significant parts beginning from the research and product development (R&D) trailed by the assembling of the items, appropriation, and deals, and finishes with post-deals checking.
The market is profoundly cutthroat, with players contending and teaming up to acquire a generous portion of the overall industry. Venture into fresher undiscovered business sectors, novel item dispatches, and choices attempted to accomplish functional proficiency are key factors that help market development. Our investigation uncovered that market players had taken on various systems and imaginative exploration and advancement methods to grow their business and secure their situation in the worldwide nitrile gloves market. As of late, joint efforts by key parts for item improvement and territorial venture into undiscovered business sectors have been utilized as a system to get functional productivity.
Segment Overview
Medical Nitrile Gloves Market has been classified into Type, usage, application, distribution channel, and end-user.
Based on type segment the global market is bifurcated into Non-Powdered and Powdered. Medical Nitrile Gloves Market, in terms of Usage, is divided into Disposable and Reusable. The application segment bifurcates the market into Examination and Surgical.
Medical Nitrile Gloves Market, by Distribution Channel, is bifurcated into Direct Selling and Medical Store. Based on End Users the global market is categorized into Hospitals & Clinics, Diagnostic Centers, ASCs, Rehabilitation Centers, and Others.
Regional Analysis
Geographically, the report on the global nitrile gloves market has been classified into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is likely to drive the global market owing to the dominating market in 2020 and is probably going to keep on directing during the evaluation time frame. This is credited to the huge number of patients experiencing COVID-19, the high pace of surgeries, and positive import arrangements in the area. The regional market growth is attributed to the prospering medical care industry, adopted technology innovations, and the presence of major market players in North America.
Europe is anticipated to register the second largest market for nitrile gloves followed by Asia-Pacific.
Key Players
The major players of the global Nitrile Gloves Market are Mercator Medical S.A, (Poland), Hartalega Holdings Berhad (Malaysia), Top Glove Corporation Bhd (Malaysia), Kossan Rubber Industries Bhd (KRI) (Malaysia), Ansell Healthcare (US), Medline Industries, In (US), 3M (US), Dynarex Corporation (US), Shield Scientific B.V. (Netherland), McKesson Corporation (US), Honeywell International Inc (US), Atrium Medical Care (US), Kimberly Clark (US), SHIELD Scientific (France), and Supermax Healthcare Limited (UK).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 17
2.1 SCOPE OF THE STUDY 17
2.2 RESEARCH OBJECTIVE 17
2.3 MARKET STRUCTURE 17
2.4 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY 19
3.1 DATA MINING 19
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 22
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23
3.6.1 BOTTOM-UP APPROACH 24
3.6.2 TOP-DOWN APPROACH 24
3.7 DATA TRIANGULATION 25
3.8 VALIDATION 25
4 MARKET DYNAMICS 26
4.1 OVERVIEW 26
4.2 DRIVERS 27
4.2.1 RISING INCIDENCES OF COVID-19 27
4.2.2 INCREASING DEMAND AND SHORTAGE OF MEDICAL NITRILE GLOVES 27
4.2.3 REFINED FEATURES AS COMPARED TO OTHER TYPES 28
4.3 RESTRAINTS 29
4.3.1 INCREASING COUNTERFEIT PRODUCTS & RISING PRICE 29
4.4 OPPORTUNITIES 30
4.4.1 NEW PRODUCT LAUNCH AND COLLABORATION FOR OPTIMIZATION OF PRODUCTION PROCESS 30
5 MARKET FACTOR ANALYSIS 31
5.1 VALUE CHAIN ANALYSIS 31
5.1.1 R&D 32
5.1.2 MANUFACTURING 32
5.1.3 DISTRIBUTION AND SALES 32
5.1.4 POST-SALES MONITORING 32
5.2 PORTER’S FIVE FORCES MODEL 32
5.2.1 BARGAINING POWER OF SUPPLIERS 33
5.2.2 BARGAINING POWER OF BUYERS 33
5.2.3 THREAT OF NEW ENTRANTS 34
5.2.4 THREAT OF SUBSTITUTES 34
5.2.5 INTENSITY OF RIVALRY 34
5.3 IMPACT ANALYSIS OF COVID-19 34
5.3.1 OVERVIEW 34
5.3.2 IMPACT ON PRICE, DEMAND & SUPPLY 35
6 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY TYPE 36
6.1 OVERVIEW 36
6.2 NON-POWDERED 37
6.3 POWDERED 37
7 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY USAGE 38
7.1 OVERVIEW 38
7.2 DISPOSABLE 39
7.3 REUSABLE 39
8 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY APPLICATION 40
8.1 OVERVIEW 40
8.2 EXAMINATION 41
8.3 SURGICAL 41
9 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY DISTRIBUTION CHANNEL 42
9.1 OVERVIEW 42
9.2 DIRECT SELLING 43
9.3 MEDICAL STORE 43
10 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY END USER 44
10.1 OVERVIEW 44
10.2 HOSPITALS & CLINICS 45
10.3 DIAGNOSTIC CENTERS 45
10.4 AMBULATORY SURGICAL CENTERS (ASCS) 46
10.5 REHABILITATION CENTERS 46
10.6 OTHERS 47
11 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY REGION 48
11.1 OVERVIEW 48
11.2 NORTH AMERICA 50
11.2.1 US 52
11.2.2 CANADA 54
11.3 EUROPE 56
11.3.1 GERMANY 58
11.3.2 UK 60
11.3.3 FRANCE 61
11.3.4 ITALY 62
11.3.5 SPAIN 64
11.3.6 REST OF EUROPE 65
11.4 ASIA PACIFIC 67
11.4.1 CHINA 69
11.4.2 JAPAN 71
11.4.3 INDIA 72
11.4.4 SOUTH KOREA 73
11.4.5 AUSTRALIA 75
11.4.6 REST OF ASIA PACIFIC 76
11.5 REST OF THE WORLD 78
11.5.1 MIDDLE EAST 80
11.5.2 AFRICA 81
11.5.3 LATIN AMERICA 83
12 COMPETITIVE LANDSCAPE 85
12.1 OVERVIEW 85
12.2 MAJOR PLAYERS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 85
12.3 COMPETITIVE BENCHMARKING 86
12.4 COMPETITOR DASHBOARD 88
12.5 DEVELOPMENTS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 89
12.5.1 ACQUISITION 89
12.5.2 PRODUCT LAUNCH/PRODUCT APPROVAL 89
12.5.3 EXPANSION 90
13 COMPANY PROFLE 91
13.1 DYNAREX CORPORATION 91
13.1.1 COMPANY OVERVIEW 91
13.1.2 FINANCIAL OVERVIEW 91
13.1.3 PRODUCTS/SERVICES OFFERED 91
13.1.4 KEY DEVELOPMENTS 91
13.1.5 SWOT ANALYSIS 92
13.1.6 KEY STRATEGIES 92
13.2 SHIELD SCIENTIFIC 93
13.2.1 COMPANY OVERVIEW 93
13.2.2 FINANCIAL OVERVIEW 93
13.2.3 PRODUCTS/SERVICES OFFERED 93
13.2.4 KEY DEVELOPMENTS 93
13.2.5 SWOT ANALYSIS 94
13.2.6 KEY STRATEGIES 94
13.3 MERCATOR MEDICAL S.A 95
13.3.1 COMPANY OVERVIEW 95
13.3.2 FINANCIAL OVERVIEW 95
13.3.3 PRODUCTS/SERVICES OFFERED 95
13.3.4 KEY DEVELOPMENTS 96
13.3.5 SWOT ANALYSIS 96
13.3.6 KEY STRATEGIES 96
13.4 HARTALEGA HOLDINGS BERHAD 97
13.4.1 COMPANY OVERVIEW 97
13.4.2 FINANCIAL OVERVIEW 97
13.4.3 PRODUCTS/SERVICES OFFERED 98
13.4.4 KEY DEVELOPMENTS 98
13.4.5 SWOT ANALYSIS 98
13.4.6 KEY STRATEGIES 99
13.5 SUPERMAX HEALTHCARE LTD 100
13.5.1 COMPANY OVERVIEW 100
13.5.2 FINANCIAL OVERVIEW 100
13.5.3 PRODUCTS/SERVICES OFFERED 100
13.5.4 KEY DEVELOPMENTS 101
13.5.5 SWOT ANALYSIS 101
13.5.6 KEY STRATEGIES 101
13.6 TOP GLOVE CORPORATION BHD 102
13.6.1 COMPANY OVERVIEW 102
13.6.2 FINANCIAL OVERVIEW 102
13.6.3 PRODUCTS/SERVICES OFFERED 103
13.6.4 KEY DEVELOPMENTS 103
13.6.5 SWOT ANALYSIS 104
13.6.6 KEY STRATEGIES 104
13.7 MCKESSON CORPORATION 105
13.7.1 COMPANY OVERVIEW 105
13.7.2 FINANCIAL OVERVIEW 105
13.7.3 PRODUCTS/SERVICES OFFERED 106
13.7.4 KEY DEVELOPMENTS 106
13.7.5 SWOT ANALYSIS 106
13.7.6 KEY STRATEGIES 107
13.8 ATRIUM MEDICAL CARE 108
13.8.1 COMPANY OVERVIEW 108
13.8.2 FINANCIAL OVERVIEW 108
13.8.3 PRODUCTS/SERVICES OFFERED 108
13.8.4 KEY DEVELOPMENTS 108
13.8.5 SWOT ANALYSIS 109
13.8.6 KEY STRATEGIES 109
13.9 KOSSAN RUBBER INDUSTRIES BHD 110
13.9.1 COMPANY OVERVIEW 110
13.9.2 FINANCIAL OVERVIEW 111
13.9.3 PRODUCTS/SERVICES OFFERED 111
13.9.4 KEY DEVELOPMENTS 112
13.9.5 SWOT ANALYSIS 112
13.9.6 KEY STRATEGIES 112
13.10 3M COMPANY 113
13.10.1 COMPANY OVERVIEW 113
13.10.2 FINANCIAL OVERVIEW 113
13.10.3 PRODUCTS OFFERED 114
13.10.4 KEY DEVELOPMENTS 114
13.10.5 SWOT ANALYSIS 114
13.10.6 KEY STRATEGIES 114
13.11 MEDLINE INDUSTRIES, INC. 115
13.11.1 COMPANY OVERVIEW 115
13.11.2 FINANCIAL OVERVIEW 115
13.11.3 PRODUCTS OFFERED 115
13.11.4 KEY DEVELOPMENTS 116
13.11.5 SWOT ANALYSIS 116
13.11.6 KEY STRATEGIES 116
13.12 ANSELL HEALTHCARE LLC 117
13.12.1 COMPANY OVERVIEW 117
13.12.2 FINANCIAL OVERVIEW 117
13.12.3 PRODUCTS OFFERED 118
13.12.4 KEY DEVELOPMENTS 118
13.12.5 SWOT ANALYSIS 119
13.12.6 KEY STRATEGIES 119
13.13 HONEYWELL INTERNATIONAL INC. 120
13.13.1 COMPANY OVERVIEW 120
13.13.2 FINANCIAL OVERVIEW 121
13.13.3 PRODUCTS/SERVICES OFFERED 121
13.13.4 KEY DEVELOPMENTS 121
13.13.5 SWOT ANALYSIS 122
13.13.6 KEY STRATEGIES 122
13.14 KIMBERLY-CLARK 123
13.14.1 COMPANY OVERVIEW 123
13.14.2 FINANCIAL OVERVIEW 123
13.14.3 PRODUCTS/SERVICES OFFERED 124
13.14.4 KEY DEVELOPMENTS 124
13.14.5 SWOT ANALYSIS 124
13.14.6 KEY STRATEGIES 124
14 APPENDIX 125
14.1 REFERENCES 125
14.2 RELATED REPORTS 125
1 EXECUTIVE SUMMARY 16
2 MARKET INTRODUCTION 17
2.1 SCOPE OF THE STUDY 17
2.2 RESEARCH OBJECTIVE 17
2.3 MARKET STRUCTURE 17
2.4 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY 19
3.1 DATA MINING 19
3.2 SECONDARY RESEARCH 19
3.3 PRIMARY RESEARCH 20
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
3.5 FORECASTING TECHNIQUES 22
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23
3.6.1 BOTTOM-UP APPROACH 24
3.6.2 TOP-DOWN APPROACH 24
3.7 DATA TRIANGULATION 25
3.8 VALIDATION 25
4 MARKET DYNAMICS 26
4.1 OVERVIEW 26
4.2 DRIVERS 27
4.2.1 RISING INCIDENCES OF COVID-19 27
4.2.2 INCREASING DEMAND AND SHORTAGE OF MEDICAL NITRILE GLOVES 27
4.2.3 REFINED FEATURES AS COMPARED TO OTHER TYPES 28
4.3 RESTRAINTS 29
4.3.1 INCREASING COUNTERFEIT PRODUCTS & RISING PRICE 29
4.4 OPPORTUNITIES 30
4.4.1 NEW PRODUCT LAUNCH AND COLLABORATION FOR OPTIMIZATION OF PRODUCTION PROCESS 30
5 MARKET FACTOR ANALYSIS 31
5.1 VALUE CHAIN ANALYSIS 31
5.1.1 R&D 32
5.1.2 MANUFACTURING 32
5.1.3 DISTRIBUTION AND SALES 32
5.1.4 POST-SALES MONITORING 32
5.2 PORTER’S FIVE FORCES MODEL 32
5.2.1 BARGAINING POWER OF SUPPLIERS 33
5.2.2 BARGAINING POWER OF BUYERS 33
5.2.3 THREAT OF NEW ENTRANTS 34
5.2.4 THREAT OF SUBSTITUTES 34
5.2.5 INTENSITY OF RIVALRY 34
5.3 IMPACT ANALYSIS OF COVID-19 34
5.3.1 OVERVIEW 34
5.3.2 IMPACT ON PRICE, DEMAND & SUPPLY 35
6 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY TYPE 36
6.1 OVERVIEW 36
6.2 NON-POWDERED 37
6.3 POWDERED 37
7 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY USAGE 38
7.1 OVERVIEW 38
7.2 DISPOSABLE 39
7.3 REUSABLE 39
8 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY APPLICATION 40
8.1 OVERVIEW 40
8.2 EXAMINATION 41
8.3 SURGICAL 41
9 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY DISTRIBUTION CHANNEL 42
9.1 OVERVIEW 42
9.2 DIRECT SELLING 43
9.3 MEDICAL STORE 43
10 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY END USER 44
10.1 OVERVIEW 44
10.2 HOSPITALS & CLINICS 45
10.3 DIAGNOSTIC CENTERS 45
10.4 AMBULATORY SURGICAL CENTERS (ASCS) 46
10.5 REHABILITATION CENTERS 46
10.6 OTHERS 47
11 GLOBAL MEDICAL NITRILE GLOVES MARKET, BY REGION 48
11.1 OVERVIEW 48
11.2 NORTH AMERICA 50
11.2.1 US 52
11.2.2 CANADA 54
11.3 EUROPE 56
11.3.1 GERMANY 58
11.3.2 UK 60
11.3.3 FRANCE 61
11.3.4 ITALY 62
11.3.5 SPAIN 64
11.3.6 REST OF EUROPE 65
11.4 ASIA PACIFIC 67
11.4.1 CHINA 69
11.4.2 JAPAN 71
11.4.3 INDIA 72
11.4.4 SOUTH KOREA 73
11.4.5 AUSTRALIA 75
11.4.6 REST OF ASIA PACIFIC 76
11.5 REST OF THE WORLD 78
11.5.1 MIDDLE EAST 80
11.5.2 AFRICA 81
11.5.3 LATIN AMERICA 83
12 COMPETITIVE LANDSCAPE 85
12.1 OVERVIEW 85
12.2 MAJOR PLAYERS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 85
12.3 COMPETITIVE BENCHMARKING 86
12.4 COMPETITOR DASHBOARD 88
12.5 DEVELOPMENTS IN THE GLOBAL MEDICAL NITRILE GLOVES MARKET 89
12.5.1 ACQUISITION 89
12.5.2 PRODUCT LAUNCH/PRODUCT APPROVAL 89
12.5.3 EXPANSION 90
13 COMPANY PROFLE 91
13.1 DYNAREX CORPORATION 91
13.1.1 COMPANY OVERVIEW 91
13.1.2 FINANCIAL OVERVIEW 91
13.1.3 PRODUCTS/SERVICES OFFERED 91
13.1.4 KEY DEVELOPMENTS 91
13.1.5 SWOT ANALYSIS 92
13.1.6 KEY STRATEGIES 92
13.2 SHIELD SCIENTIFIC 93
13.2.1 COMPANY OVERVIEW 93
13.2.2 FINANCIAL OVERVIEW 93
13.2.3 PRODUCTS/SERVICES OFFERED 93
13.2.4 KEY DEVELOPMENTS 93
13.2.5 SWOT ANALYSIS 94
13.2.6 KEY STRATEGIES 94
13.3 MERCATOR MEDICAL S.A 95
13.3.1 COMPANY OVERVIEW 95
13.3.2 FINANCIAL OVERVIEW 95
13.3.3 PRODUCTS/SERVICES OFFERED 95
13.3.4 KEY DEVELOPMENTS 96
13.3.5 SWOT ANALYSIS 96
13.3.6 KEY STRATEGIES 96
13.4 HARTALEGA HOLDINGS BERHAD 97
13.4.1 COMPANY OVERVIEW 97
13.4.2 FINANCIAL OVERVIEW 97
13.4.3 PRODUCTS/SERVICES OFFERED 98
13.4.4 KEY DEVELOPMENTS 98
13.4.5 SWOT ANALYSIS 98
13.4.6 KEY STRATEGIES 99
13.5 SUPERMAX HEALTHCARE LTD 100
13.5.1 COMPANY OVERVIEW 100
13.5.2 FINANCIAL OVERVIEW 100
13.5.3 PRODUCTS/SERVICES OFFERED 100
13.5.4 KEY DEVELOPMENTS 101
13.5.5 SWOT ANALYSIS 101
13.5.6 KEY STRATEGIES 101
13.6 TOP GLOVE CORPORATION BHD 102
13.6.1 COMPANY OVERVIEW 102
13.6.2 FINANCIAL OVERVIEW 102
13.6.3 PRODUCTS/SERVICES OFFERED 103
13.6.4 KEY DEVELOPMENTS 103
13.6.5 SWOT ANALYSIS 104
13.6.6 KEY STRATEGIES 104
13.7 MCKESSON CORPORATION 105
13.7.1 COMPANY OVERVIEW 105
13.7.2 FINANCIAL OVERVIEW 105
13.7.3 PRODUCTS/SERVICES OFFERED 106
13.7.4 KEY DEVELOPMENTS 106
13.7.5 SWOT ANALYSIS 106
13.7.6 KEY STRATEGIES 107
13.8 ATRIUM MEDICAL CARE 108
13.8.1 COMPANY OVERVIEW 108
13.8.2 FINANCIAL OVERVIEW 108
13.8.3 PRODUCTS/SERVICES OFFERED 108
13.8.4 KEY DEVELOPMENTS 108
13.8.5 SWOT ANALYSIS 109
13.8.6 KEY STRATEGIES 109
13.9 KOSSAN RUBBER INDUSTRIES BHD 110
13.9.1 COMPANY OVERVIEW 110
13.9.2 FINANCIAL OVERVIEW 111
13.9.3 PRODUCTS/SERVICES OFFERED 111
13.9.4 KEY DEVELOPMENTS 112
13.9.5 SWOT ANALYSIS 112
13.9.6 KEY STRATEGIES 112
13.10 3M COMPANY 113
13.10.1 COMPANY OVERVIEW 113
13.10.2 FINANCIAL OVERVIEW 113
13.10.3 PRODUCTS OFFERED 114
13.10.4 KEY DEVELOPMENTS 114
13.10.5 SWOT ANALYSIS 114
13.10.6 KEY STRATEGIES 114
13.11 MEDLINE INDUSTRIES, INC. 115
13.11.1 COMPANY OVERVIEW 115
13.11.2 FINANCIAL OVERVIEW 115
13.11.3 PRODUCTS OFFERED 115
13.11.4 KEY DEVELOPMENTS 116
13.11.5 SWOT ANALYSIS 116
13.11.6 KEY STRATEGIES 116
13.12 ANSELL HEALTHCARE LLC 117
13.12.1 COMPANY OVERVIEW 117
13.12.2 FINANCIAL OVERVIEW 117
13.12.3 PRODUCTS OFFERED 118
13.12.4 KEY DEVELOPMENTS 118
13.12.5 SWOT ANALYSIS 119
13.12.6 KEY STRATEGIES 119
13.13 HONEYWELL INTERNATIONAL INC. 120
13.13.1 COMPANY OVERVIEW 120
13.13.2 FINANCIAL OVERVIEW 121
13.13.3 PRODUCTS/SERVICES OFFERED 121
13.13.4 KEY DEVELOPMENTS 121
13.13.5 SWOT ANALYSIS 122
13.13.6 KEY STRATEGIES 122
13.14 KIMBERLY-CLARK 123
13.14.1 COMPANY OVERVIEW 123
13.14.2 FINANCIAL OVERVIEW 123
13.14.3 PRODUCTS/SERVICES OFFERED 124
13.14.4 KEY DEVELOPMENTS 124
13.14.5 SWOT ANALYSIS 124
13.14.6 KEY STRATEGIES 124
14 APPENDIX 125
14.1 REFERENCES 125
14.2 RELATED REPORTS 125
